Antibiogram and Antibiotic Resistance Patterns in Bacterial Isolates from Hayatabad Medical Complex, Peshawar

  21 October 2024

This study evaluated the resistance patterns of Gram-negative and Gram-positive bacteria at Hayatabad Medical Complex (HMC) to commonly used antibiotics, focusing on identifying multidrug-resistant (MDR) pathogens. A retrospective study from January to September 2022 used antibiogram data to assess sensitivity patterns for antibiotics such as Ceftazidime, Imipenem, Meropenem, Amikacin, Oxacillin, and Teicoplanin. Acinetobacter showed a high level of resistance, with only 6% sensitivity to Ceftazidime, indicating a high level of resistance. This could lead to increased healthcare costs and poorer patient outcomes. Acinetobacter also showed only 37% sensitivity to Ciprofloxacin, confirming its status as an MDR pathogen in hospital settings. The study highlights the urgent need for robust antimicrobial stewardship programs, enhanced infection control practices, ongoing surveillance of resistance patterns, healthcare provider education, and regional collaboration to address antimicrobial resistance.

Further reading: Cureus
Author(s): Mehwash Iftikhar et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed